Pitfalls of diagnosing pituitary hypoplasia in the patients with short stature
dc.contributor.author | Yilmaz, Seniha Kiremitci | |
dc.contributor.author | Ovali, Gulgun Yilmaz | |
dc.contributor.author | Kizilay, Deniz Ozalp | |
dc.contributor.author | Tarhan, Serdar | |
dc.contributor.author | Ersoy, Betul | |
dc.date.accessioned | 2024-08-31T07:50:03Z | |
dc.date.available | 2024-08-31T07:50:03Z | |
dc.date.issued | 2024 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | PurposeHeight age (HA) and bone age (BA) delay is well known in the patients with short stature. Therefore assessing pituitary hypoplasia based on chronological age (CA) might cause overdiagnosis of pituitary hypoplasia. We aimed to investigate the diagnostic and prognostic value of the PH and PV based on CA, HA, or BA in the patients with GHD.MethodsFifty-seven patients with severe and 40 patients with partial GHD and 39 patients with ISS assigned to the study. For defining the most accurate diagnosis of pituitary hypoplasia, PH and PV were evaluated based on CA, BA and HA. The relationship of each method with clinical features was examined.ResultsThe mean PV was significantly larger in patients with ISS compared to the GH-deficient patients. PV was more correlated with clinical features including height SDS, stimulated GH concentration, IGF-1 and IGFBP-3 SDS, height velocity before and after rGH therapy. We found BA-based PV could discriminate GHD from ISS (Sensitivity: 17%, specificity: 98%, positive predictive value: 94%, negative predictive value: 39%), compared to the other methods based on PH or PV respect to CA and HA. 3% of patients with ISS, 17% of patients with GHD had pituitary hypoplasia based on PV-BA.ConclusionPV based on BA, has the most accurate diagnostic value for defining pituitary hypoplasia. But it should be kept in mind that there might be still misdiagnosed patients by this method. PV is also a significant predictor for the rGH response. | en_US |
dc.description.sponsorship | Scientific and Technological Research Council of Turkiye (TUBITAK) | en_US |
dc.description.sponsorship | Open access funding provided by the Scientific and Technological Research Council of Turkiye (TUBITAK). | en_US |
dc.identifier.doi | 10.1007/s12020-024-03951-9 | |
dc.identifier.issn | 1355-008X | |
dc.identifier.issn | 1559-0100 | |
dc.identifier.pmid | 38969909 | en_US |
dc.identifier.scopus | 2-s2.0-85197565744 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12020-024-03951-9 | |
dc.identifier.uri | https://hdl.handle.net/11454/105097 | |
dc.identifier.wos | WOS:001263318600001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Endocrine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | 20240831_U | en_US |
dc.subject | Pituitary Volume | en_US |
dc.subject | Pituitary Hypoplasia | en_US |
dc.subject | Bone Age | en_US |
dc.subject | Short Stature | en_US |
dc.subject | Recombinant Gh Response | en_US |
dc.subject | Multiple Pituitary Hormone Deficiency | en_US |
dc.title | Pitfalls of diagnosing pituitary hypoplasia in the patients with short stature | en_US |
dc.type | Article | en_US |